[Allergy to betalactams: myth and realities].
Allergic reactions to penicillins have been reported since the 1950s, shortly after their introduction as therapeutic agents. An increasing number of reported anaphylactic reactions and other adverse effects proved this to be a serious public health problem. Fifty years later, betalactam-induced hypersensitivity is the most frequent cause of drug reaction and has been the source of a great number of publications. Clinically, betalactam-induced allergic reactions may be immediate or non-immediate according to the time interval between drug intake and the occurrence of symptoms. The diagnosis of betalactam hypersensitivity is based on skin tests methods, in vitro tests and drug provocation test. There are three classical methods for skin testing: prick, intradermal, and patch. These tests are still the most sensitive techniques. In vitro tests, mainly based on the quantification of IgE antibodies to betalactams by immunoassay (Fluorescent Enzyme Immunoassay [FEIA]), may sometimes yield useful complementary information. Drug provocation tests must be performed with the required caution and the adequate indication. Algorithms are available for both immediate and non-immediate reactions to provide a practical approach for patient evaluation. They are based on the following data: clinical history, skin tests, FEIA, and drug provocation tests. Finally, cross reactivity between betalactams has been reported, especially between penicillins and cephalosporins. Their frequency was long over-estimated, but recent evidence, indicates that cross reactivity between betalactams has become rare. Administration of cephalosporins in patients with a history of penicillin allergy requires performing skin testing with penicillin, the probably allergenic drug, and the cephalosporin to be prescribed.
Chaabane
A
A
Laboratoire de pharmacologie, faculté de médecine, rue Avicenne, 5019 Monastir, Tunisie. amelchb@yahoo.fr
Aouam
K
K
Boughattas
N A
NA
Chakroun
M
M
D000707:Anaphylaxis / Q000453:epidemiology; D001985:Bronchial Provocation Tests; D003429:Cross Reactions; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000453:epidemiology*; D006241:Haptens / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D010406:Penicillins / Q000276:immunology*; D012680:Sensitivity and Specificity; D012882:Skin Tests; D047090:beta-Lactams / Q000737:chemistry / Q000276:immunology*
D006241:Haptens; D010406:Penicillins; D047090:beta-Lactams; D007073:Immunoglobulin E